Literature DB >> 10544937

The Leu564 factor XIIIA variant results in significantly lower plasma factor XIII levels than the Pro564 variant.

L Gallivan, A F Markham, R Anwar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10544937

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  4 in total

1.  Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease.

Authors:  Ana Bronić; Goran Ferenčak; Robert Bernat; Jasna Leniček-Krleža; Jerka Dumić; Sanja Dabelić
Journal:  J Med Biochem       Date:  2021-03-12       Impact factor: 3.402

2.  Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.

Authors:  D M O Pruissen; F R Rosendaal; J W Gorter; A A Garcia; L J Kappelle; A Algra
Journal:  J Neurol       Date:  2007-11-14       Impact factor: 4.849

3.  Combination of thrombophilic gene polymorphisms as a cause of increased the risk of recurrent pregnancy loss.

Authors:  Raheleh Torabi; Saeed Zarei; Hojjat Zeraati; Amir Hassan Zarnani; Mohammad Mehdi Akhondi; Reza Hadavi; Elham Savadi Shiraz; Mahmood Jeddi-Tehrani
Journal:  J Reprod Infertil       Date:  2012-04

4.  Factor XIII polymorphism and risk of aneurysmal subarachnoid haemorrhage in a south Indian population.

Authors:  Arati Suvatha; M K Sibin; Dhananjaya I Bhat; K V L Narasingarao; Vikas Vazhayil; G K Chetan
Journal:  BMC Med Genet       Date:  2018-09-05       Impact factor: 2.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.